Scinai Immunotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.99	1.96	4.87	14.08	17.37	2.93
Cash & Short-Term Investments	0.99	1.96	4.87	14.08	17.37	2.93
Cash Growth	-79.51%	-59.67%	-65.40%	-18.99%	492.54%	-86.02%
Accounts Receivable	0.14	0.08	-	-	-	-
Other Receivables	-	-	-	-	-	0.37
Total Trade Receivables	0.14	0.08	-	-	-	0.37
Other Current Assets	0.38	0.34	0.58	0.3	0.47	-
Total Current Assets	1.51	2.39	5.45	14.37	17.84	3.31
Net Property, Plant & Equipment	10.33	11.06	12.03	12.7	14.19	14.26
Other Long-Term Assets	-	-	-	-	-	0.15
Total Assets	11.84	13.45	17.47	27.07	32.04	17.71
Accounts Payable	0.66	0.38	0.54	0.72	1	0.58
Accrued Expenses	0.96	1.01	0.85	1.24	1.07	0.39
Short-Term Debt	-	-	-	-	-	18.81
Current Portion of Leases	0.5	0.42	0.4	0.38	0.38	0.2
Total Current Liabilities	2.12	1.81	1.78	2.34	2.44	19.98
Long-Term Debt	0.29	0.26	19.37	20.08	27.16	-
Long-Term Leases	1.57	1.4	0.8	1.08	1.45	1.89
Other Long-Term Liabilities	0	0	0.1	5.33	-	0.38
Total Long-Term Liabilities	1.86	1.67	20.26	26.49	28.61	2.28
Total Liabilities	3.98	3.47	22.04	28.83	31.05	22.26
Preferred Stock	5.63	5.63	-	-	-	-
Additional Paid-in Capital	125.64	123.63	119.51	116.08	113.08	96.54
Accumulated Other Comprehensive Income	-1.74	-1.74	-1.74	-2.01	-2.06	-
Retained Earnings	-121.67	-117.54	-122.34	-115.84	-110.04	-101.09
Total Common Shareholders' Equity	7.86	9.98	-4.57	-1.76	0.98	-4.54
Shareholders' Equity	7.86	9.98	-4.57	-1.76	0.98	-4.54
Total Liabilities & Equity	11.84	13.45	17.47	27.07	32.04	17.71
Total Debt	2.36	2.09	20.56	21.54	28.99	20.9
Net Cash (Debt)	-1.37	-0.12	-15.69	-7.47	-11.61	-17.97
Net Cash Per Share	-1.04	-0.15	-40.17	-39.61	-82.26	-16217.32
Book Value	7.86	9.98	-4.57	-1.76	0.98	-4.54
Book Value Per Share	5.97	12.37	-11.70	-9.34	6.96	-4099.41
Tangible Book Value	7.86	9.98	-4.57	-1.76	0.98	-4.54
Tangible Book Value Per Share	5.97	12.37	-11.70	-9.34	6.96	-4099.41

Updated Sep 2, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q